Physician profile
Littee Anna Sam
NPI 1316444508
$1,887.56
in general payments reported to CMS, 2019-2025
27 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.64 · 2022: $728 · 2023: $536 · 2024: $178 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.57 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $178.47 | 2022-2025 | Verquvo, Capvaxive |
| Genzyme Corporation | $123.42 | 2022-2023 | |
| Abiomed | $114.12 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.67 | 2022-2023 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $105.57 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $103.34 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.08 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $92.94 | 2023-2025 | Bodyguardian, Varithena Administration Pack, Watchman Flx |
| Amgen INC. | $85.53 | 2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $80.80 | 2021-2023 | |
| Pfizer INC. | $72.00 | 2022-2023 | |
| Janssen Biotech, INC. | $71.19 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $64.07 | 2022 | |
| Edwards Lifesciences Corporation | $58.94 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $51.13 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Qol Medical, LLC | $36.20 | 2022 | |
| Redhill Biopharma INC. | $35.29 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.58 | 2022 | |
| Intercept Pharmaceuticals, INC. | $30.45 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.93 | 2024 | Lifevest |
| Cardiva Medical, INC. | $24.91 | 2025 | Cardiva Vascade 6/7f Vcs |
| Medtronic, INC. | $22.32 | 2021 | |
| Glaxosmithkline, LLC. | $17.73 | 2025 | Shingrix, Arexvy |
| Braintree Laboratories, INC. | $17.72 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.31 | 2022 | |
| Kestra Medical Technology Services, INC. | $14.28 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Littee Sam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.